Melanoma Drugs Market by Therapy (Chemotherapy, Immunotherapy and Targeted Therapy) and Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Global melanoma drugs market is expected to reach USD 4.71 billion by 2022, growing at a CAGR of 15.0% between 2016 and 2022.

Request Brochure Request Discount

31-Jan-2017 | Number of pages: 110 | Report Code: ZMR-889 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the melanoma drugs market on a global and regional level. The study provides historic data of 2014 along with a forecast for 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the melanoma drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the melanoma drugs market on a global level.

In order to give the users of this report a comprehensive view on the melanoma drugs market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Therapy segments and cancer type segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new therapy launch, agreements, partnerships, collaborations & joint ventures, research& development, therapy and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, Therapy portfolio of various companies along with patent analysis (2011-2016) bifurcated into a patent trend, patent share by company and patent analysis according to the region.

The study provides a decisive view on the melanoma drugs market by segmenting the market based on therapy and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022. Based on therapy the market is segmented into chemotherapy, immunotherapy and targeted therapy. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for melanoma drugs based on individual therapy in all the regions and countries.

The report also includes detailed profiles of end players such as Amgen, Bristol-Myers Squibb, Hoffmann-La Roche Ltd, Genentech Inc., Janssen Biotech, Inc., Novartis International AG., Pfizer, Sanofi, Takeda Pharmaceutical Company Limited and Teva Pharmaceuticals among others.

This report segments the global melanoma drugs market as follows:

Global Melanoma drugs Market: Therapy Segment Analysis

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy

Global Melanoma drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Crohn’s Disease Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3033 | Report Format:

Global Crohns Disease Market: Overview An inflammatory disease of bowel affecting any part of the Gastro-Intestinal Tract (GI Tract) is termed as Crohns disease. It is classified into a segment of chronic disease. Crohns disease is considered to impact nearly every part of an individuals life, a...Read More

Anti-Neoplastic Agents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3024 | Report Format:

Global Anti-Neoplastic Agents Market: Overview Anti-neoplastic agents are primarily used as a first-line treatment for cancer therapy as well as in combination with radiation or surgical therapy. A lot of anti-neoplastic agents are accessible commercially for the therapy of various kinds of canc...Read More

Kidney Fibrosis Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-2989 | Report Format:

Global Kidney Fibrosis Treatment Market: Overview Fibrosis is the growth of extreme connective tissue owing to some injury or some disease. Disease in the kidney can cause kidney fibrosis. In this state, the kidneys fail to work properly which gradually leads to severe conditions. Kidney transpl...Read More

Oncology Based In-vivo CRO Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2982 | Report Format:

Global Oncology Based In-vivo CRO Market: Overview CRO basically stands for contract research organization which presents research services to a pharmaceutical, biotechnology, and medical devices key players on the basis of the contract. CRO offers services such as clinical research, biologic as...Read More

H1N1 Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2024

Price : $ 3999.00 | Report Code: ZMR-2976 | Report Format:

H1N1 Vaccines Market: Overview The H1N1 flu epidemic created a public health emergency in 2009. It also created an opportunity for vaccine manufacturers to exhibit that working with various initiatives, both private and government-held entities around the world, they could manufacture and distri...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.